All Blogs

Apr 01, 2021

Amgen to acquire Rodeo for $55M; Novartis expands radioligand portfolio; Organon acquires Alydia for $240M; Forma announces positive FT-4202 dose levels


Mar 31, 2021

How Depression Is Eroding The Mental And The Physical Health Of The Society?


Apr 05, 2021

Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?


Mar 30, 2021

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing


Apr 02, 2021

A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers


Mar 29, 2021

Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement


Mar 26, 2021

How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?


Mar 25, 2021

Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand hits goal in phase 3; EpimAb raises $120M in Series C


Mar 24, 2021

How Fitness Trackers Are Shaping the Future of Healthcare?


Mar 23, 2021

Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche’s Tecentriq Results in NSCLC